Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Harrap

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|November 27, 1992
Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivativesJ Balzarini, E De Clercq, P Serafinowski, et al.
British Journal of Cancer|August 1, 1991
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesP Mistry, L R Kelland, G Abel, et al.
Biochemical Pharmacology|June 15, 1987
The comparative pharmacokinetics of carboplatin and cisplatin in mice and ratsZ H Siddik, D R Newell, F E Boxall, et al.
European Journal of Cancer|December 1, 1974
Factors determining cell sensitivity to methotrexate: studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell linesM H Tattersall, R C Jackson, S T Jackson, et al.
European Journal of Cancer|October 1, 1973
Combination chemotherapy: the interaction of methotrexate and 5-fluorouracilM H Tattersall, R C Jackson, T A Connors, et al.
British Journal of Cancer|December 1, 1992
Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesS Y Loh, P Mistry, L R Kelland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugsK R Harrap, M Jones, J Siracky, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell linesM G Ormerod, C O'Neill, D Robertson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120M I Walton, P Goddard, L R Kelland, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discoveryL R Kelland, M Jones, G Abel, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|November 27, 1992
Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivativesJ Balzarini, E De Clercq, P Serafinowski, et al.
British Journal of Cancer|August 1, 1991
The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesP Mistry, L R Kelland, G Abel, et al.
Biochemical Pharmacology|June 15, 1987
The comparative pharmacokinetics of carboplatin and cisplatin in mice and ratsZ H Siddik, D R Newell, F E Boxall, et al.
European Journal of Cancer|December 1, 1974
Factors determining cell sensitivity to methotrexate: studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell linesM H Tattersall, R C Jackson, S T Jackson, et al.
European Journal of Cancer|October 1, 1973
Combination chemotherapy: the interaction of methotrexate and 5-fluorouracilM H Tattersall, R C Jackson, T A Connors, et al.
British Journal of Cancer|December 1, 1992
Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesS Y Loh, P Mistry, L R Kelland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugsK R Harrap, M Jones, J Siracky, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell linesM G Ormerod, C O'Neill, D Robertson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120M I Walton, P Goddard, L R Kelland, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discoveryL R Kelland, M Jones, G Abel, et al.
Pageof 14